Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery

ESSENTIALS: Recombinant von Willebrand factor (rVWF) is effective in von Willebrand disease (VWD). A phase 3 study of rVWF, with/without recombinant factor VIII (rFVIII) before surgery in VWD. Overall rVWF's efficacy was rated excellent/good; rVWF was administered alone in most patients. rVWF w...

Descripción completa

Detalles Bibliográficos
Autores principales: Peyvandi, F., Mamaev, A., Wang, J.‐D., Stasyshyn, O., Timofeeva, M., Curry, N., Cid, A. R., Yee, T. T., Kavakli, K., Castaman, G., Sytkowski, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
CLINICAL HAEMOSTASIS AND THROMBOSIS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379610/
https://www.ncbi.nlm.nih.gov/pubmed/30362288
http://dx.doi.org/10.1111/jth.14313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379610/
https://www.ncbi.nlm.nih.gov/pubmed/30362288
http://dx.doi.org/10.1111/jth.14313

Ejemplares similares